Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
British Patient Capital Limited investment portfolio
British Patient Capital Limited has made numerous investments in companies such as Paragraf, Quantexa, and Tenpoint Therapeutics Holding within the AI sector.
vc
Portfolio
34
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (34)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Accurx Limited AccuRx operates a software platform that enables clinicians to securely message patients, share clinical information and arrange video consultations. The service is used by NHS primary‑care and other health organisations to improve communication and collaboration. | Software & IT | London | Confirmed | 2025-07-25 |
| Cambridge Gan Devices Limited Cambridge GaN Devices Ltd is a fabless semiconductor company that designs, develops and commercialises gallium‑nitride (GaN) power transistors and integrated circuits, including its ICeGaN enhancement‑mode devices that operate like MOSFETs. Its products are aimed at automotive manufacturers and other sectors that require high‑efficiency, low‑loss power‑electronics solutions. | Healthcare & Life Sciences | Cambridge | Confirmed | 2025-10-17 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (32)
British Patient Capital Limited's positions across portfolio companies2026
- SERIES C PREFERRED SHARES 0 → 402,781
- SERIES B 11,415,257 → 14,050,596
Articles (6)
- 25 Aug 2026
- British Patient Capital takes 11.9% stake in Sitala Bio Ltd, anti-inflammatory medicines firm23 Aug 2026Sitala Bio
- Janus Henderson takes 5.6% stake in Tenpoint Therapeutics Holding Limited23 Aug 2026Tenpoint Therapeutics Holding
- 21 Aug 2026
- DCVC VII QS, LLC and Kembara Fund I FCR each take 1.7%, while Firgun Ventures Fund I SCSP takes 1.0% in Quantum Motion Technologies21 Jul 2026Quantum Motion Technologies
- 27 Apr 2026